Cardiol Therapeutics Inc.
CRDLNASDAQHealthcareDrug Manufacturers - Specialty & Generic
As of Oct 26, 2026 close
- Market cap
- $128.73M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.88$2.34
- Volume (live)
- -
- Avg. volume (3M)
- 1.34M
Cardiol Therapeutics (CRDL) Stock Price & Financial Analysis
Cardiol Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.11 - $1.15 |
|---|---|
| 52-Week High | $2.34 |
| 52-Week Low | $0.88 |
| Open | $1.12 |
| Volume (last close) | 580.16K |
| Average Volume (3M) | 1.34M |
| 50-Day MA | $1.72 |
|---|---|
| 200-Day MA | $1.30 |
| 1-Year Change | −1.71% |
| Market Cap | 128.73M |
|---|---|
| Shares Outstanding | 114.94M |
| Price to Book (P/B) | 7.51 |
| EV/EBITDA | -4.74 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Cardiol Therapeutics at a Glance
As of the Oct 26, 2026 close, Cardiol Therapeutics (CRDL) has a market capitalization of $128.73M.
As of its latest reported balance sheet, it holds $18.61M in cash and securities against $76.33K of debt, a net cash position of $18.53M.
Cardiol Therapeutics does not currently pay a dividend.
The share price is down 1.7% over the past year. At $1.12 (the Oct 26, 2026 close) it sits within its 52-week range of $0.88 to $2.34, below its 200-day moving average of $1.30.
Frequently Asked Questions About Cardiol Therapeutics
What is the current stock price for CRDL?
As of the Oct 26, 2026 close, CRDL stock trades at $1.12. The 52-week range is $0.88–$2.34, with a day range of $1.11–$1.15.
What is the P/E ratio for CRDL?
The P/E ratio (Price-to-Earnings) for CRDL is shown in the Key Statistics section. This valuation metric helps compare Cardiol Therapeutics Inc. to industry peers.
Does CRDL pay dividends?
Cardiol Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for CRDL?
Analyst ratings and recommendations for CRDL are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of CRDL?
As of the Oct 26, 2026 close, Cardiol Therapeutics's market capitalization is $128.7M, classifying it as a micro-cap company. Cardiol Therapeutics operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.